which, to our knowledge, is the first genetically confirmed case published in scientific literature of NCMD in Australia.
METHODS
DNA was extracted from lymphocytes, and array comparative genomic hybridization analysis (Illumina Infinium CytoSNP-850K BeadChip, San Diego, CA) was performed to look for copy number variants, with manual analysis of MCDR1 and MCDR3. Whole blood was collected from the patient in an Ethylenediaminetetraacetic acid (EDTA) tube and DNA extracted using a standard automated method (QIAsymphony® AS instrument, Qiagen, Hombrechtikon,Switzerland) as recommended by the manufacturer. Sanger sequencing of the PRDM13 gene and the NCMD mutation hotspot 13 kb was performed by Molecular Vision Laboratory (Hillsboro, OR). Informed written consent was obtained from the family for genetic testing and for publication purpose. [6] .
The research was conducted in accordance with the Declaration of Helsinki, and local institutional ethical requirements were met. The research, which adhered to ethical principles of medical research involving human subjects, was conducted in accordance with the Declaration of Helsinki, and local institutional ethical requirements were met.
RESULTS
A 4-year-old boy failed his preschool vision screening, and was referred to an ophthalmologist. His best corrected visual acuity (BCVA) was 6/24 in the right eye and 6/12 in the left eye. He had a variable angle right exotropia and normal anterior segments in both eyes. Fundoscopic examination reported central bilateral excavated geographic atrophy six to seven disc diameters with surrounding submacular fibrosis. These circular lesions had some peripheral hyperpigmentation with raised fibrotic edges ( Figure 1A,B) . He was subsequently seen in the Ocular Genetics clinic at the Women's and Children's Hospital [4] .
Family history revealed the father also had bilateral macular scarring, with a provisional diagnosis of congenital toxoplasmosis. He had been diagnosed when he was an infant, and had not progressed. On assessment of the boy's father, his BCVA in the right eye was 6/6 and in the left eye was 6/60. Fundoscopic examination revealed in the right eye a half disc diameter area of RPE atrophy involving the central macula, with scattered, fine drusen in the background retina ( Figure 1C ). In the left eye, a macular scar of approximately one disc diameter was noted with surrounding multiple fine drusen in the macular area of the posterior pole ( Figure 1D ). The boy's mother and younger brother had normal ocular examinations. The family were Australian with a mixture of German and English heritage. During array comparative genomic hybridization, no copy number variants were identified, and Sanger sequencing identified a previously reported single base substitution (chromosome 6: 99,593,111 (G>C) NC_000006.11(GRCh38); g. 100040987G>C). The father was also shown to have this mutation, but it was not present in the unaffected sibling, confirming that the mode of inheritance is autosomal dominant.
DISCUSSION
The mutation reported was previously reported by Small et al. [6] as "V2", which was in the French and German families he studied. This is not the "V1" mutation of the original NCMD family of Lefler, Wadsworth, and Sidbury [2] , although V1 and V2 are within 100 bp of each other in a non-coding region in the same DNASE1 binding site. The "V2" mutation has been more commonly reported in England and Europe, and this Australian family may likely share a common founder [8] . In conclusion, we believe this is the first confirmed case of NCMD in Australia, published in a scientific journal. This case highlights the similarities between NCMD and more commonly recognized conditions, such as ocular toxoplasmosis, and suggests that NCMD may be underdiagnosed in the general population or mistaken for conditions such as ocular toxoplasmosis [3] .
